Ciardiello F - Search Results

1

Nivolumab in Heavily Pretreated Metastatic Gastric Cancer Patients: Real-Life Data from a Western Population.

Petrillo A, Tirino G, Zito Marino F, Pompella L, Sabetta R, Panarese I, Pappalardo A, Caterino M, Ventriglia A, Laterza MM, Morgillo F, Orditura M, Ciardiello F, Franco R, De Vita F. Petrillo A, et al. Among authors: ciardiello f. Onco Targets Ther. 2020 Jan 29;13:867-876. doi: 10.2147/OTT.S229813. eCollection 2020. Onco Targets Ther. 2020. PMID: 32099391 Free PMC article.

2

Epidermal growth factor receptor tyrosine kinase inhibitors in late stage clinical trials.

Ciardiello F, De Vita F, Orditura M, De Placido S, Tortora G. Ciardiello F, et al. Expert Opin Emerg Drugs. 2003 Nov;8(2):501-14. doi: 10.1517/14728214.8.2.501. Expert Opin Emerg Drugs. 2003. PMID: 14662002 Review.

3

Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma.

De Vita F, Orditura M, Lieto E, Infusino S, Morgillo F, Martinelli E, Castellano P, Romano C, Ciardiello F, Catalano G, Pignatelli C, Galizia G. De Vita F, et al. Among authors: ciardiello f. Cancer. 2004 Jan 15;100(2):270-8. doi: 10.1002/cncr.11911. Cancer. 2004. PMID: 14716760 Free article.

4

The role of EGFR inhibitors in nonsmall cell lung cancer.

Ciardiello F, De Vita F, Orditura M, Tortora G. Ciardiello F, et al. Curr Opin Oncol. 2004 Mar;16(2):130-5. doi: 10.1097/00001622-200403000-00008. Curr Opin Oncol. 2004. PMID: 15075904 Review.

5

Determination of molecular marker expression can predict clinical outcome in colon carcinomas.

Galizia G, Lieto E, Ferraraccio F, Orditura M, De Vita F, Castellano P, Imperatore V, Romano C, Ciardiello F, Agostini B, Pignatelli C. Galizia G, et al. Among authors: ciardiello f. Clin Cancer Res. 2004 May 15;10(10):3490-9. doi: 10.1158/1078-0432.CCR-0960-03. Clin Cancer Res. 2004. PMID: 15161706

6

Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracycline-induced cardiotoxicity (review).

Orditura M, Quaglia F, Morgillo F, Martinelli E, Lieto E, De Rosa G, Comunale D, Diadema MR, Ciardiello F, Catalano G, De Vita F. Orditura M, et al. Among authors: ciardiello f. Oncol Rep. 2004 Sep;12(3):549-56. Oncol Rep. 2004. PMID: 15289836 Review.

7

Antitumor activity of ZD6474, a vascular endothelial growth factor-2 and epidermal growth factor receptor small molecule tyrosine kinase inhibitor, in combination with SC-236, a cyclooxygenase-2 inhibitor.

Tuccillo C, Romano M, Troiani T, Martinelli E, Morgillo F, De Vita F, Bianco R, Fontanini G, Bianco RA, Tortora G, Ciardiello F. Tuccillo C, et al. Among authors: ciardiello f. Clin Cancer Res. 2005 Feb 1;11(3):1268-76. Clin Cancer Res. 2005. PMID: 15709198

8

Epidermal growth factor receptor (EGFR) inhibitors in cancer therapy.

Ciardiello F, De Vita F. Ciardiello F, et al. Prog Drug Res. 2005;63:93-114. doi: 10.1007/3-7643-7414-4_5. Prog Drug Res. 2005. PMID: 16265878 Review. No abstract available.

9

p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate.

Galizia G, Ferraraccio F, Lieto E, Orditura M, Castellano P, Imperatore V, La Manna G, Pinto M, Ciardiello F, La Mura A, De Vita F. Galizia G, et al. Among authors: ciardiello f. J Surg Oncol. 2006 Mar 1;93(3):241-52. doi: 10.1002/jso.20402. J Surg Oncol. 2006. PMID: 16482605

10

Cetuximab in the treatment of colorectal cancer.

Ciardiello F, De Vita F, Orditura M, Comunale D, Galizia G. Ciardiello F, et al. Future Oncol. 2005 Apr;1(2):173-81. doi: 10.1517/14796694.1.2.173. Future Oncol. 2005. PMID: 16555987 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

624 results

Search Page